Profile
Mike Blaire is currently working as an Executive Advisor at h LLC.
Prior to this, he worked as the CEO of Diamondback Drugs LLC from 2001 to 2017 and as the CEO of Mrb Pharmacies, Inc. from 1981 to 1993.
He completed his undergraduate degree from the University of Rochester in 1980, a graduate degree from Arizona State University in 1998, and another undergraduate degree from St. John's University in 1983.
Mike Blaire active positions
| Companies | Position | Start |
|---|---|---|
SHERIDAN CP LP
SHERIDAN CP LP Investment ManagersFinance Sheridan CP invests in lower middle market companies located in the United States and Canada with an EBITDA of USD 5 to 25 million. The firm focuses on healthcare and consumer. It participates in buyout and recapitalizations transactions with an investment between USD 30 to 150 million and also acquires control position. | Consultant / Advisor | - |
Former positions of Mike Blaire
| Companies | Position | End |
|---|---|---|
Diamondback Drugs LLC
Diamondback Drugs LLC Agricultural Commodities/MillingProcess Industries Provides veterinary medical services | Chief Executive Officer | 2017-05-29 |
Mrb Pharmacies, Inc. | Chief Executive Officer | 1993-03-30 |
Training of Mike Blaire
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SHERIDAN CP LP
SHERIDAN CP LP Investment ManagersFinance Sheridan CP invests in lower middle market companies located in the United States and Canada with an EBITDA of USD 5 to 25 million. The firm focuses on healthcare and consumer. It participates in buyout and recapitalizations transactions with an investment between USD 30 to 150 million and also acquires control position. | Finance |
Diamondback Drugs LLC
Diamondback Drugs LLC Agricultural Commodities/MillingProcess Industries Provides veterinary medical services | Process Industries |
Mrb Pharmacies, Inc. |
- Stock Market
- Insiders
- Mike Blaire
















